Mylan announces launch of generic for oral contraceptive Yaz®
Mylan announced the U.S. launch of Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0.02 mg, a generic version of Bayer's Yaz® Tablets. Mylan received final approval from the FDA for its ANDA, which is indicated for use by women to prevent pregnancy and for treatment of acne vulgaris. April 25, 2018